Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Joy Mosser-Goldfarb MD

Joy L. Mosser-Goldfarb MD

Assistant Professor of Pediatrics, Division of Dermatology, Nationwide Children’s Hospital; Dermatology Residency Director, Ohio State University, Columbus, Ohio

Joy L. Mosser, MD, is a dermatologist at Nationwide Children’s Hospital. Dr. Mosser is board certified in dermatology and pediatric dermatology. Past clinical studies have included the use of topical steroids for atopic dermatology, tacrolimus for atopic dermatitis, pimecrolimus for atopic dermatitis and lactic acid for ichthyosis vulgaris. Dr. Mosser devotes most of her career to medical education and mentoring. Her educational activities include lectures to dermatology residents at The Ohio State University College of Medicine and Ohio Health, pediatric residents at Nationwide Children’s Hospital, and Ohio State University Medical Students.

 

Recent Contributions to PracticeUpdate:

  1. Numerical Significance of Pediatric Skin Lesions and the Recommended Evaluation
  2. Effectiveness and Safety of Treatment With Upadacitinib in Adolescents and Adults With Atopic Dermatitis
  3. A Multidisciplinary Atopic Dermatitis Program for Managing Patients With Difficult-to-Control Atopic Dermatitis
  4. Outcomes of Using a Moisturizing Cream With 20% Urea for the Treatment of Patients With Keratosis Pilaris
  5. Risk of Comorbidities Among Children With Atopic Dermatitis
  6. Evolution of Pediatric Vulvar Lichen Sclerosus After Menarche
  7. Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis
  8. Differences Between Children and Adults With Hidradenitis Suppurativa
  9. JAK Inhibitors for Atopic Dermatitis
  10. Adolescents' Perspectives on Atopic Dermatitis Treatment

Most Read This Week

Recently Updated